Merck & Co. said a European Medicines Agency panel recommended expanded approval of the drugmaker's blockbuster cancer treatment Keytruda in two types of gynecologic cancers.

Merck & Co., Inc. MRK announced that the FDA had approved its blockbuster anti-PD-1 therapy, Keytruda (pembrolizumab), for a ...

If you want to avoid toxic fertilizers and insecticides, skip those with organophosphates, a toxic group of chemicals that can kill large dogs in even small doses, according to the Merck Veterinary ...

How To Buy Merck & Company Shares By now you're likely curious about how to participate in the market for Merck & Co MRK – be it to purchase shares, or even attempt to bet against the company.

Is Merck a good buy right now? Investors can buy Merck's stock at a fairly reasonable multiple of 15 times next year's earnings (based on analyst estimates). It's a reasonably valued stock at a ...

Merck (NYSE: MRK) is a top pharmaceutical company coming off a good quarter that shows it is growing its top and bottom lines. Even with that growth, the stock still trades at a fairly modest ...

We recently compiled a list of the 10 Best Cancer Stocks To Buy Now. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against the other cancer stocks.

On Tuesday, TD (TSX:TD) Cowen reaffirmed its confidence in Merck & Co Inc (NYSE:MRK), maintaining a Buy stock rating with a steady price target of $140.00. The firm's analysis included a reassessment ...